Histologic features and predicting prognosis in ulcerative colitis patients with mild endoscopic activity
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: We aimed to evaluate the histologic features predictive of prognosis and correlate them with endoscopic findings in patients with ulcerative colitis (UC) having complete or partial mucosal healing (MH). Methods: We prospectively collected and reviewed data from patients with UC who underwent colonoscopy or sigmoidoscopy with biopsy. Complete and partial MH were defined as Mayo endoscopic subscores (MESs) of 0 and 1, respectively. Histologic variables, including the Nancy index (NI), predicting disease progression (defined as the need for medication upgrade or hospitalization/surgery), were evaluated and correlated with endoscopic findings. Results: Overall, 441 biopsy specimens were collected from 194 patients. The average follow-up duration was 14.7 ± 7.4 months. There were 49 (25.3%) and 68 (35.1%) patients with MESs of 0 and 1, respectively. Disease progression occurred only in patients with an MES of 1. NI ≥ 3 was significantly correlated with disease progression during follow-up. Mucosal friability on endoscopy was significantly correlated with NI ≥ 3 (61.1% in NI < 3 vs. 88.0% in NI ≥ 3; p = 0.013). Conclusions: Histological activity can help predict the prognosis of patients with UC with mild endoscopic activity. Mucosal friability observed on endoscopy may reflect a more severe histological status, which can be a risk factor for disease progression.
Abstract
Background/Aims: We aimed to evaluate the histologic features predictive of prognosis and correlate them with endoscopic findings in patients with ulcerative colitis (UC) having complete or partial mucosal healing (MH). Methods: We prospectively collected and reviewed data from patients with UC who underwent colonoscopy or sigmoidoscopy with biopsy. Complete and partial MH were defined as Mayo endoscopic subscores (MESs) of 0 and 1, respectively. Histologic variables, including the Nancy index (NI), predicting disease progression (defined as the need for medication upgrade or hospitalization/surgery), were evaluated and correlated with endoscopic findings. Results: Overall, 441 biopsy specimens were collected from 194 patients. The average follow-up duration was 14.7 ± 7.4 months. There were 49 (25.3%) and 68 (35.1%) patients with MESs of 0 and 1, respectively. Disease progression occurred only in patients with an MES of 1. NI ≥ 3 was significantly correlated with disease progression during follow-up. Mucosal friability on endoscopy was significantly correlated with NI ≥ 3 (61.1% in NI < 3 vs. 88.0% in NI ≥ 3; p = 0.013). Conclusions: Histological activity can help predict the prognosis of patients with UC with mild endoscopic activity. Mucosal friability observed on endoscopy may reflect a more severe histological status, which can be a risk factor for disease progression.
참고문헌 (36)
- Ungaro R, "Ulcerative colitis", Lancet, 389, pp.1756~1770 (2017)
- Fukuda T, "Current new challenges in the management of ulcerative colitis", Intest Res, 17, pp.36~44 (2019)
- Kim YS, "Impact of inflammatory bowel disease on daily life: an online survey by the Korean Association for the Study of Intestinal Diseases", Intest Res, 15, pp.338~344 (2017)
- Peyrin-Biroulet L, "Selecting Therapeutic Targets in Inflammatory Bowel Disease(STRIDE) : determining therapeutic goals for treat-to-target", Am J Gastroenterol, 110, pp.1324~1338 (2015)
- Turner D, "STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treatto-target strategies in IBD", Gastroenterology, 160, pp.1570~1583 (2021)
- Kim DJ, "Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis", Intest Res, 16, pp.563~570 (2018)
- Schroeder KW, "Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study", N Engl J Med, 317, pp.1625~1629 (1987)
- Meucci G, "Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine : a prospective, multicenter study", Inflamm Bowel Dis, 18, pp.1006~1010 (2012)
- Barreiro-de Acosta M, "Evaluation of the risk of relapse in ulcerative colitis according to the degree of mucosal healing(Mayo 0 vs 1) : a longitudinal cohort study", J Crohns Colitis, 10, pp.13~19 (2016)
- Neurath MF, "Mucosal healing in inflammatory bowel diseases : a systematic review", Gut, 61, pp.1619~1635 (2012)
- Colombel JF, "Early mucosal healing with infliximab is associated with improved longterm clinical outcomes in ulcerative colitis", Gastroenterology, 141, pp.1194~1201 (2011)
- Shah J, "Relationship between Mayo endoscopic score and histological scores in ulcerative colitis : a prospective study", JGH Open, 4, pp.382~386 (2019)
- Pai RK, "The emerging role of histologic disease activity assessment in ulcerative colitis", Gastrointest Endosc, 88, pp.887~898 (2018)
- Bryant RV, "Beyond endoscopic mucosal healing in UC : histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up", Gut, 65, pp.408~414 (2016)
- Ozaki R, "Histological risk factors to predict clinical relapse in ulcerative colitis with endoscopically normal mucosa", J Crohns Colitis, 12, pp.1288~1294 (2018)
- Park S, "Histological disease activity as a predictor of clinical relapse among patients with ulcerative colitis : systematic review and meta-analysis", Am J Gastroenterol, 111, pp.1692~1701 (2016)
- Lobatón T, "Prognostic value of histological activity in patients with ulcerative colitis in deep remission : a prospective multicenter study", United European Gastroenterol J, 6, pp.765~772 (2018)
- Zittan E, "Low fecal calprotectin correlates with histological remission and mucosal healing in ulcerative colitis and colonic Crohn’s disease", Inflamm Bowel Dis, 22, pp.623~630 (2016)
- Dignass A, "Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1 : definitions and diagnosis", J Crohns Colitis, 6, pp.965~990 (2012)
- Reinink AR, "Endoscopic mucosal healing predicts favorable clinical outcomes in inflammatory bowel disease : a meta-analysis", Inflamm Bowel Dis, 22, pp.1859~1869 (2016)
- Marchal-Bressenot A, "Development and validation of the Nancy histological index for UC", Gut, 66, pp.43~49 (2017)
- Bressenot A, "Comparing histological activity indexes in UC", Gut, 64, pp.1412~1418 (2015)
- Landis JR, "The measurement of observer agreement for categorical data", Biometrics, 33, pp.159~174 (1977)
- Korelitz BI, "Mucosal healing as an index of colitis activity : back to histological healing for future indices", Inflamm Bowel Dis, 16, pp.1628~1630 (2010)
- Truelove SC, "Biopsy studies in ulcerative colitis", Br Med J, 1, pp.1315~1318 (1956)
- Mosli MH, "Histologic scoring indices for evaluation of disease activity in ulcerative colitis", Cochrane Database Syst Rev, 5, pp.CD011256~ (2017)
- Magro F, "ECCO position paper : harmonization of the approach to ulcerative colitis histopathology", J Crohns Colitis, 14, pp.1503~1511 (2020)
- Ponte A, "Impact of histological and endoscopic remissions on clinical recurrence and recurrence-free time in ulcerative colitis", Inflamm Bowel Dis, 23, pp.2238~2244 (2017)
- Yoon H, "Incremental benefit of achieving endoscopic and histologic remission in patients with ulcerative colitis : a systematic review and meta-analysis", Gastroenterology, 159, pp.1262~1275 (2020)
- Bessissow T, "Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing", Am J Gastroenterol, 107, pp.1684~1692 (2012)
- Riley SA, "Microscopic activity in ulcerative colitis : what does it mean?", Gut, 32, pp.174~178 (1991)
- Jauregui-Amezaga A, "Accuracy of advanced endoscopy and fecal calprotectin for prediction of relapse in ulcerative colitis : a prospective study", Inflamm Bowel Dis, 20, pp.1187~1193 (2014)
- Liverani E, "How to predict clinical relapse in inflammatory bowel disease patients", World J Gastroenterol, 22, pp.1017~1033 (2016)
- Bitton A, "Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis", Gastroenterology, 120, pp.13~20 (2001)
- Parian AM, "Serrated epithelial change is associated with high rates of neoplasia in ulcerative colitis patients : a case-controlled study and systematic review with meta-analysis", Inflamm Bowel Dis, 27, pp.1475~1481 (2021)
- Parian A, "Association between serrated epithelial changes and colorectal dysplasia in inflammatory bowel disease", Gastrointest Endosc, 84, pp.87~95 (2016)